Ind-Swift Laboratories Limited approved the incorporation of a wholly owned subsidiary ("WOS") in Dubai, United Arab Emirates (UAE) in the name and style of "Ind-Swift (Dubai) Ltd." or such other name as may be approved by the concerned authorities of the UAE. The Company shall further intimate on receipt of Certificate of Incorporation as and when the same is received by the Company. The WOS intends to strategically invest in pharmaceutical and allied activities.

This includes exploring potential acquisitions, tie-ups, or joint ventures. Additionally, the Company aims to establish and operate pharmaceutical manufacturing units.